Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1993 May;83(5):749–751. doi: 10.2105/ajph.83.5.749

Anergy compromises screening for tuberculosis in high-risk populations.

S R Zoloth 1, S Safyer 1, J Rosen 1, D Michaels 1, P Alcabes 1, E Bellin 1, C Braslow 1
PMCID: PMC1694677  PMID: 8484464

Abstract

Anergy may occur in groups at high risk for tuberculosis, compromising tuberculin skin testing. Within New York City's correctional system, anergy prevalence was 25% among opiate users referred to detoxification programs and 3% in the general population. Correlates of anergy were recent weight loss and needle sharing. The high prevalence of anergy among opiate users compromises the utility of tuberculosis screening and suggests the need for routine chest x-rays to detect pulmonary tuberculosis in some high-risk-populations.

Full text

PDF
749

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braun M. M., Truman B. I., Maguire B., DiFerdinando G. T., Jr, Wormser G., Broaddus R., Morse D. L. Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection. JAMA. 1989 Jan 20;261(3):393–397. [PubMed] [Google Scholar]
  2. Brown S. M., Stimmel B., Taub R. N., Kochwa S., Rosenfield R. E. Immunologic dysfunction in heroin addicts. Arch Intern Med. 1974 Dec;134(6):1001–1006. [PubMed] [Google Scholar]
  3. Frazer I. H., Collins E. J., Fox J. S., Jones B., Oliphant R. C., Mackay I. R. Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens. Clin Immunol Immunopathol. 1985 May;35(2):182–190. doi: 10.1016/0090-1229(85)90064-9. [DOI] [PubMed] [Google Scholar]
  4. Graham N. M., Nelson K. E., Solomon L., Bonds M., Rizzo R. T., Scavotto J., Astemborski J., Vlahov D. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA. 1992 Jan 15;267(3):369–373. [PubMed] [Google Scholar]
  5. Kniker W. T., Anderson C. T., Roumiantzeff M. The multi-test system: a standardized approach to evaluation of delayed hypersensitivity and cell-mediated immunity. Ann Allergy. 1979 Aug;43(2):73–79. [PubMed] [Google Scholar]
  6. Sears S. D., Fox R., Brookmeyer R., Leavitt R., Polk B. F. Delayed hypersensitivity skin testing and anergy in a population of gay men. Clin Immunol Immunopathol. 1987 Nov;45(2):177–183. doi: 10.1016/0090-1229(87)90032-8. [DOI] [PubMed] [Google Scholar]
  7. Snider D. E., Jr, Hutton M. D. Tuberculosis in correctional institutions. JAMA. 1989 Jan 20;261(3):436–437. [PubMed] [Google Scholar]
  8. Spencer S. S., Morton A. R. Tuberculosis surveillance in a state prison system. Am J Public Health. 1989 Apr;79(4):507–509. doi: 10.2105/ajph.79.4.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Stead W. W. Undetected tuberculosis in prison. Source of infection for community at large. JAMA. 1978 Dec 1;240(23):2544–2547. doi: 10.1001/jama.240.23.2544. [DOI] [PubMed] [Google Scholar]
  10. Weisfuse I. B., Greenberg B. L., Back S. D., Makki H. A., Thomas P., Rooney W. C., Rautenberg E. L. HIV-1 infection among New York City inmates. AIDS. 1991 Sep;5(9):1133–1138. doi: 10.1097/00002030-199109000-00013. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES